Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery
Yu Toyoda(University of Tokyo Hospital), Hiroshi Suzuki(Obihiro University of Agriculture and Veterinary Medicine)
Cited by 28
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|690
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|173
ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload
|Scientific Reports|2014|163
Embryo Spacing and Implantation Timing Are Differentially Regulated by LPA3-Mediated Lysophosphatidic Acid Signaling in Mice1
|Biology of Reproduction|2007|119